TY  - RPRT
TI  - Integrated molecular and immune profiling identifies FOXA1 as a complementary co-target to MUC1 for bispecific immunotherapy in breast cancer.
AU  - Debolina Chakraborty
AU  - Subhadip Kundu
AU  - Vinit Gupta
AU  - Mansi Patel
AU  - Sudhir Kumar Rawal
AU  - Samson Mani
PY  - 2026
DO  - 10.1007/s10142-026-02030-8
UR  - https://pubmed.ncbi.nlm.nih.gov/42726297/
ID  - 42726297
ER  -